Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Conolog Cp -- Ignore unavailable to you. Want to Upgrade?

To: jjs64 who wrote (344)	8/19/2001 4:21:36 PM
From: StockDung	Respond to of 428

Geoffery J. Eiten and Conolog's IR Company tied to known stock manipulator MARIO IACOVIELLO who was associated with Notorious Boiler Room La Jolla Securities Corp google.com National Financial Network - Management Team Mr. Iacoviello gained extensive experience in the financial industry through a decade of work in senior management positions with prestigious companies such as Baron Chase Securities, Oppenheimer, and Rodman & Renshaw. Through his work with these firms, Mr. Iacoviello has gained expertise in a variety of areas, including financing and the development of integral marketing strategies resulting in increased profitability. He has seamlessly adapted these skills for utilization in the arena of investor relations. NFN's clients and their investor base benefit from his broad financial background. ===================================== CIVIL ACTION AGAINST MARIO IACOVIELLO The Commission announced the filing on September 7 of a final judgment on consent against Mario J. Iacoviello of Vista, California in the United States District Court for the Southern District of New York. According to the Commission's complaint, filed on May 14, 1998, Iacoviello violated the antifraud provisions of the federal securities laws while employed as a registered representative with the San Diego branch office of La Jolla Securities Corp. by accepting undisclosed compensation for recommending and selling stock in RMS Titanic, Inc. to his clients. Without admitting or denying the allegations in the Commission's complaint, Iacoviello consented to a permanent injunction against future violations of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934, and Rule 10b-5 thereunder. Iacoviello also consented to pay disgorgement of $30,325 plus prejudgment interest thereon of $16,155.30, subject to a waiver of all but $10,000 based upon Iacoviello's demonstrated inability to pay. [SEC v. Paul V. Montle, LS Capital Corporation, Paul V. Culotta, Carol C. Martino, CMA Noel, Ltd., Mario J. Iacoviello, Ilan Arbel and Europe American Capital Corporation, USDC, SDNY, 98 Civ. 3446, MP] (LR-16277) ====================================== SEC says former LS Capital officer Montle fined WASHINGTON, July 13 (Reuters) - Paul Montle, former president and chief executive of LS Capital Corp., was ordered to pay more than $415,000 and barred from serving as an officer or director for five years for alleged fraud involving three other companies in the early 1990s, regulators said on Friday. Montle, 53, who resides in Massachusetts, was also barred from participating in the sale of securities for five years, according to the Securities and Exchange Commission. The ruling, which was handed down on Thursday by a U.S. federal judge in New York, fines Montle $50,000, orders him to pay back more than $365,000 in disgorgement and interest, and bars him from holding executive roles in publicly-traded companies, closes an SEC civil case filed back in May 1998. Montle, while a CEO and director of Viral Testing Systems Corp., which marketed an HIV diagnostic test called "Fluorognost," more than doubled revenues and overstated revenue projections in two trade publications in 1992 and in a 1993 company press release, the SEC alleged. As chairman and CEO of gambling casino operator Lone Star Casino Corp., he intentionally left out in SEC filings the sale of more than 1 million shares to foreign investors in 1993 and altered minutes from board meetings and the company's financial books to cover it up, the SEC alleged. He was also accused of profiting more than $187,000 by manipulating in 1993 the stock of RMS Titanic Inc. , which owns the salvage rights to the sunken Titanic. Montle's "violations involving fraud and deceit were numerous and ongoing," and his "actions were knowing departures from the securities laws," the SEC quoted federal district judge Milton Pollack as saying. The ruling was made after a four-day trial in May, the SEC said. His attorney did not immediately return a telephone call seeking comment. 18:44 07-13-01

To: jjs64 who wrote (344)	11/1/2001 10:08:15 AM
From: StockDung	Respond to of 428

Silk Purse, Cows Ear Conolog Reports Year-End Results for Fiscal 2001; Operation Profits Up 89% SOMERVILLE, N.J.--(BUSINESS WIRE)--Oct. 29, 2001--Conolog Corporation (NASDAQ: CNLG, CNLGW) reported on October 26, 2001 its year-end results for the fiscal year ended July 31, 2001. The Company reported total revenues of $6,080,318 for the fiscal year ended July 31, 2001 or an increase of 8.36% compared to revenues of $5,611.132 reported for year-end fiscal 2000. The Company realized income from operations of $323,945 or an 89% increase compared to $170,029 for the year ended July 31, 2000. During fiscal year 2001, the Company incurred a total of $1,730,257 in one-time charges in write-offs of obsolete or excess inventories, legal settlements, cost of selling, product development, and amortization of product costs, resulting in a net loss of $2,782,451 or ($1.24) per share. This compares to a net loss of $1,883,663 or ($1.11) per share in fiscal year 2000. Conolog President, Marc Benou, stated, "Going forward, we expect the September 11th incident to have a negative impact in the first quarter FY02; however we are extremely optimistic that the second quarter FY02 will allow the Company to make up for lost ground, and we are confident that we will achieve profitability in that quarter." Benou continued, "During fiscal year 2001, the Company successfully introduced its eight channel all-digital PDR2000 at the Western Power Conference in Spokane, Washington and this week it is introducing the unit at the IEEE/PES T&D (Transmission and Distribution) Conference and Exposition in Atlanta, Georgia. We believe the Company is now at the forefront of protection equipment, offering complete lines of both analog and digital protection products." About Conolog Corporation: Conolog Corporation provides engineering and design services, technical personnel placement, and computer maintenance services to a variety of industries, government organizations, and public utilities nationwide. The Company's INIVEN division manufactures a line of digital signal processing systems, including transmitters, receivers and multiplexers. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products introduced by competitors, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. CONTACT: Conolog Corporation Marc Benou, 908/722-8081 www.conolog.com or National Financial Network Geoffrey Eiten, 781/444-6100 or 877/385-0977, ext. 613 geiten@nfnonline.com www.nfnonline.com/cnlg KEYWORD: NEW JERSEY NEW YORK BW2539 OCT 29,2001 12:39 PACIFIC 15:39 EASTERN

To: jjs64 who wrote (344)	11/15/2001 11:41:42 PM
From: StockDung	Respond to of 428

cows ear->Conolog Reports Year-End Results for Fiscal 2001; Operation Profits Up 89% SOMERVILLE, N.J.--(BUSINESS WIRE)--Oct. 29, 2001--Conolog Corporation (NASDAQ: CNLG, CNLGW) reported on October 26, 2001 its year-end results for the fiscal year ended July 31, 2001. The Company reported total revenues of $6,080,318 for the fiscal year ended July 31, 2001 or an increase of 8.36% compared to revenues of $5,611.132 reported for year-end fiscal 2000. The Company realized income from operations of $323,945 or an 89% increase compared to $170,029 for the year ended July 31, 2000. During fiscal year 2001, the Company incurred a total of $1,730,257 in one-time charges in write-offs of obsolete or excess inventories, legal settlements, cost of selling, product development, and amortization of product costs, resulting in a net loss of $2,782,451 or ($1.24) per share. This compares to a net loss of $1,883,663 or ($1.11) per share in fiscal year 2000. Conolog President, Marc Benou, stated, "Going forward, we expect the September 11th incident to have a negative impact in the first quarter FY02; however we are extremely optimistic that the second quarter FY02 will allow the Company to make up for lost ground, and we are confident that we will achieve profitability in that quarter." Benou continued, "During fiscal year 2001, the Company successfully introduced its eight channel all-digital PDR2000 at the Western Power Conference in Spokane, Washington and this week it is introducing the unit at the IEEE/PES T&D (Transmission and Distribution) Conference and Exposition in Atlanta, Georgia. We believe the Company is now at the forefront of protection equipment, offering complete lines of both analog and digital protection products." About Conolog Corporation: Conolog Corporation provides engineering and design services, technical personnel placement, and computer maintenance services to a variety of industries, government organizations, and public utilities nationwide. The Company's INIVEN division manufactures a line of digital signal processing systems, including transmitters, receivers and multiplexers. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products introduced by competitors, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. CONTACT: Conolog Corporation Marc Benou, 908/722-8081 www.conolog.com or National Financial Network Geoffrey Eiten, 781/444-6100 or 877/385-0977, ext. 613 geiten@nfnonline.com www.nfnonline.com/cnlg KEYWORD: NEW JERSEY NEW YORK BW2539 OCT 29,2001 12:39 PACIFIC 15:39 EASTERN

To: jjs64 who wrote (344)	2/20/2002 11:17:21 PM
From: StockDung	Respond to of 428

and it turns out Roland Perry the editor of that news letter is La Crim extrodinare ----------------------------------- As noted above, the "peg" for Royce's e-mail spam is the new tout from Morgan's Special Situation Report stock newsletter, which is put out by Roland Perry, a Beverly Hills-based publisher of seven such letters. Royce's e-mail says of Morgan's: "The editor stated that Royce is 'eerily' similer (sic) to Biomerica, which was recommended by Morgan's at $1.80 and ran to $9.75 in a little more then (sic) a year (1995-1996)." * What the spam doesn't say is that Perry has received Royce stock in compensation for reviewing the company. How much stock? He declined to say. Perry would obviously benefit if a herd of new investors suddenly bid Royce's share price higher, based on Perry's and the company's hype. But no one would benefit more than Ken Pappas, Royce's president, who owns 2,050,000 of the firm's 3,134,167 shares outstanding. YOUR MONEY: If It's a 'Spam' Come-On, Beware of the Potential for Baloney Los Angeles Times (LT) - SUNDAY October 20, 1996 Edition: Home Edition Section: Business Page: 1 Pt. D Story Type: Column Word Count: 1,232 Tom Petruno; Times Staff Writer -------------------------------------------------------------------------------- The blessing of the Internet and technology in general is also their curse: You can reach anyone, and anyone can reach you--even when you don't want to be reached. Take, for example, this unsolicited e-mail (electronic mail) that has shown up in computer mailboxes of perhaps millions of people around the country recently. It's from a company called Royce Biomedical, which professes to be a manufacturer and exporter of home testing kits for the HIV virus, for other diseases and for pregnancy. Royce also thinks it has a hot stock that the world deserves to know about. "Royce Biomedical announced that it recently received a strong 'BUY' recommendation from Morgan's Special Situation Report," the e-mail begins. "The report recommended Royce, currently in the $2 range, with an initial price target of $6." The come-on gets much bolder as you read further: "The size of Royce's target markets combined with its small capitalization leave an EXPLOSIVE potential for the company's share price over the next 6-12 months." If that hook doesn't get you, you're invited onto Royce's home page on the World Wide Web, where you learn a little about its diagnostic test kits and where it expects to sell them, a little about management, but absolutely nothing about the company's finances. You do find out, however, that while Royce's 7,000-square-foot "operations" center is in Irvine, its corporate office is in Vancouver, Canada--a city infamous for its population of penny-stock promoters, many of dubious background. Royce's unsolicited e-mail is known as a "spam," and spamming is a growing irritation for Internet users, who often sign on to find their electronic mailboxes filled with unwanted come-ons from companies with stuff to sell. There's nothing illegal about marketing in and of itself, of course. Anyone can send you any sales pitch through the mail or over the phone. The Internet is just another delivery system, and as with more traditional mediums, you can simply choose to ignore messages that don't interest you. * But there must be something particularly galling about investment pitches made over the Internet, because the Securities and Exchange Commission is getting an earful from angry spamees. "Spams are just about the No. 1 complaint we get here with regard to the Internet," said John Stark, counsel for Internet projects at the SEC in Washington. He estimated that he gets 30 to 40 complaints a day about such pitches. Yet the SEC can only monitor spam activity. It can't prohibit it, nor would it try, Stark said, reminding spamees that the 1st Amendment also extends to cyberspace. Even so, he added, the 1st Amendment "doesn't allow someone to commit fraud." Drawing that line, however, is a tough exercise when it comes to stock promotion. It's not hard to understand why a small company looking for investors would market over the Internet. The medium is low-cost, high-speed and has the potential to reach millions of people worldwide. And unlike a "cold call" telephone solicitation from a broker--who may not be able to get the pitch out before you hang up--an Internet message sits there, in full, in your electronic mailbox. Chances are you'll be tempted to read it through. * Royce Biomedical's spam is about as brash as they get. The firm has little in sales to speak of, and assets of about $800,000, according to its operations chief in Irvine, Chandravadan Patel. Royce became publicly traded not through a formal underwriting, but via its principals' purchase of a "shell" firm with basically no assets--but with the all-important ability to issue stock. By convincing a couple of brokerages to make a market in the stock, Royce qualified in May to have its shares traded on the Bulletin Board, the barely regulated part of the Nasdaq market. Royce's e-mail bursts with optimism about the future. The company's strategic plan is to sell its diagnostic medical tests in the Third World at cheap prices. But Royce itself won't be doing the selling: It will require foreign distributors for that, and the e-mail informs potential investors that "Eight major medical product distributors, covering several key target countries, are presently negotiating distribution contracts." Moreover, the company says confidently, "Any one of these sales agents could give Royce the cash flow necessary to become a highly successful company and a stellar stock performer." Asked to expound a bit more, Patel--whose bio says he holds a master's degree in organic synthetic chemistry and a doctorate in clinical biochemistry--confirmed that Royce doesn't have federal approval to sell its diagnostic kits in the United States, because "we'd need a couple hundred thousand dollars to get that" by first sponsoring clinical trials. So instead, the kits will be sold overseas at what Patel said could be "100% profit." His potential distributors, he said, "are saying that they have orders and they're ready to market." And how many competitors would Royce face in Third World countries? For HIV tests, Patel estimated there are "only five or six companies" competing. Dan Maarsman, who handles Royce's communications from Vancouver, said the company expects to compete through low prices on its kits because, as he noted without a trace of irony, "we're not Johnson & Johnson--we can produce the same kits without a lot of overhead." * However much Royce might like to sell disease-testing kits to poor people overseas, its e-mail campaign suggests its more immediate goal is to sell American investors on its stock, thereby driving the share price up. Maarsman is nothing if not candid about the intended consequence of the e-mail campaign. "If people have stock and want to sell it," he noted, they need interested buyers. "Getting the word out to the public is the toughest thing." Luckily for companies like Royce, there is no shortage of people to help get the word out--for the right compensation. As noted above, the "peg" for Royce's e-mail spam is the new tout from Morgan's Special Situation Report stock newsletter, which is put out by Roland Perry, a Beverly Hills-based publisher of seven such letters. Royce's e-mail says of Morgan's: "The editor stated that Royce is 'eerily' similer (sic) to Biomerica, which was recommended by Morgan's at $1.80 and ran to $9.75 in a little more then (sic) a year (1995-1996)." * What the spam doesn't say is that Perry has received Royce stock in compensation for reviewing the company. How much stock? He declined to say. Perry would obviously benefit if a herd of new investors suddenly bid Royce's share price higher, based on Perry's and the company's hype. But no one would benefit more than Ken Pappas, Royce's president, who owns 2,050,000 of the firm's 3,134,167 shares outstanding. Pappas isn't a medical man by training. Rather, he heads a Vancouver restaurant chain called Knight and Day. "They're big restaurants," Maarsman said. Does Royce Biomedical have a future? Your guess is probably as good as management's, and maybe even better. Experienced investors will undoubtedly recoil instantly from stock spams like Royce's, given their wild hype. But less-knowledgeable investors may be sucked in without thinking about the risks involved, and who stands to benefit most if the stock price suddenly surges. At the SEC, John Stark says the commission doesn't think it needs to write new rules governing investment information on the Internet. All the SEC can hope, he said, is that people use common sense. -------------------------------------------------------------------------------- Keywords: MARKETING; ELECTRONIC MAIL; INTERNET (COMPUTER NETWORK); SECURITIES; ROYCE BIOMEDICAL (COMPANY) 961020 LT961003 -------------------------------------------------------------------------------- Copyright © 1996 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. latimes.com

To: jjs64 who wrote (344)	2/20/2002 11:20:10 PM
From: StockDung	Respond to of 428

More lies->According to the Internet Stock Review, its top ten picks for 2001 included Datastand Technology (OTCBB: DATT chart, msgs) up 566%, Digital River (Nasdaq: DRIV chart, msgs) up 300%, Aptimus (Nasdaq: APTM chart, msgs) up 200%, Delano Tech (Nasdaq: DTEC chart, msgs) up 178%, eUniverse (Nasdaq: EUNI chart, msgs) up 155%, Aptimus II (APTM) up 104%, Conolog (Nasdaq: CNLG chart, msgs) up 72%, Cross Media Marketing (AMEX: XMM chart, msgs) up 71%, Marketwatch.com (Nasdaq: MKTW chart, msgs) up 66% and Airspan Networks (Nasdaq: AIRN chart, msgs) up 62%. California Stock Review Adds EMB Corp. to its Watch List HUNTINGTON BEACH, Calif., Feb. 12, 2002 (PRIMEZONE via COMTEX) -- James E. Shipley, President of EMB Corporation (OTCBB: EMBI chart, msgs), (Berlin:EMBI.BE), (Frankfurt:EMBI.F), and (Hamburg:EMBI: EMBI:H), announced today that EMB Corp. has been added to the California Stock Review, an investment newsletter specializing in California-based publicly traded companies. The California Stock Review is a newly launched publication of the Internet PR Group, a highly regarded investment research and investor relations firm, located in Beverly Hills, CA, which additionally publishes the Internet Stock Review. The Internet Stock Review, which was launched in December of 1998, has enjoyed great success since inception, including during 2001 with its top ten picks registering gains in excess of 177 percent, on average. According to the Internet Stock Review, its top ten picks for 2001 included Datastand Technology (OTCBB: DATT chart, msgs) up 566%, Digital River (Nasdaq: DRIV chart, msgs) up 300%, Aptimus (Nasdaq: APTM chart, msgs) up 200%, Delano Tech (Nasdaq: DTEC chart, msgs) up 178%, eUniverse (Nasdaq: EUNI chart, msgs) up 155%, Aptimus II (APTM) up 104%, Conolog (Nasdaq: CNLG chart, msgs) up 72%, Cross Media Marketing (AMEX: XMM chart, msgs) up 71%, Marketwatch.com (Nasdaq: MKTW chart, msgs) up 66% and Airspan Networks (Nasdaq: AIRN chart, msgs) up 62%. Of the entire 35 stocks added to the Watch List in 2001 (closed and/or open at year end), 71% gained in value and the overall percentage gain of all picks was 50.7%. The Internet PR Group is one of the nation's leading investment firms, specializing in creating market awareness programs for publicly traded companies involved in the Internet, restaurant, gaming & entertainment industries. It also publishes three industry specific newsletters. Editor Roland Perry stated, "We're excited to launch the California Stock Review, which is in line with our policy to provide industry and/or geographic specific coverage to the markets and we're pleased to have added EMB Corp to the Watch List." Mr. Perry continued, "EMB Corp. is the first company which we will be covering in the California Stock Review. After reporting a record year of over $540 million in funded loan production, record revenues in excess of $9 million and profitability, EMB subsidiary First Guaranty Financial Corp. saw consistent growing demands for its mortgage products in all sectors. We expect the Company to continue to perform well, as it strives to reach its 2002 goal of $650 million in fundings and we are pleased to help the Company tell its story to our broad base of investors. We are equally excited about its recently announced $2 million financing with Paramount Financial Group, Inc." To request an investor kit for EMB Corporation, please call Justin Keener at (650) 292-1585, or email EMBI@EquityBroadcast.com. About EMB Corporation: EMB Corporation is a financial services holding company, which provides a network to mortgage brokers, both retail and wholesale through our wholly owned mortgage companies, currently including American National Mortgage and First Guaranty Financial Corporation. Mortgages originated by our group of companies may be held temporarily for investment, or may be sold to third parties / financial institutions, or may be secured, packaged, and sold as mortgage backed securities. For further information about the Company please look at our website. embcorp.net, or embcorporation.com A number of statements referenced in this Release and the CEOcast and EquityBroadcast.com interviews, are forward-looking statements, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans projections, objectives, goals, assumption of future events or performance are not statement of historical fact and may be "forward-looking statements." Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this actions may be identified through the use of words such as "expects," "will," "anticipates," " estimates," "believes" or statements indicating future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses, and other factors described in the Company's' filings with the Securities and Exchange Commission. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. The Company does not undertake any responsibility to update the "forward-looking statements" contained in this news release. The results of previous "picks" by the Internet Stock Review listed in this press release were provided by the Internet Stock Review, and while the information is believed to be accurate, there is no warranty or representation that this information is correct. Please see the Internet Stock Review disclaimer as it relates to Rule 17B at the website and in its welcome letter at internetstockreview.com. SUBJECT: Business Contracts KEYWORDS: BANKING CONTACT: EquityBroadcast / EquityThunder, Inc. Justin Keener, Investor Relations (650) 292-1585 EMBI@EquityBroadcast.com DELIVERED BY PRIMEZONE MEDIA NETWORK 800-307-6627 Copyright (c) 2002. PrimeZone Media Network, Inc.

To: jjs64 who wrote (344)	5/3/2002 4:53:32 PM
From: StockDung	Respond to of 428

Geoff Eiten recommends Surgilight Inc and is also IR Wednesday March 22, 8:28 am Eastern Time Company Press Release OTC Financial Network Announces Investment Opinion On SurgiLight Inc. OTC Financial Network Issues Research Report On SurgiLight Inc. ORLANDO, Fla.-March 22, 2000- SurgiLight Inc. (OTCBB:SRGL)announced today that OTC Financial Network, a division of National Financial Communications Corporation (NFC) of Needham, Massachusetts, has issued an in-depth analytic report on the Company. The report is available online, at www.otcfn.com/srgl/4page.html. The report is also available for reprint by calling 781/444-6100, ext.11. Geoffrey J. Eiten, president of National Financial Communications, commented, ``The market for laser applications in the ophthalmology and dermatology industries is enormous, and SurgiLight, Inc. has the innovative technology to assume a position of leadership.'' SurgiLight is a world leader in the development of new infrared technologies, and a pioneer and inventor of scanning lasers and laser presbyopia reversal. The Company continues to receive royalty income from international eye laser and cosmetic centers. The presbyopia potential market is over $150 billion in US and $1.4 trillion worldwide, according to SurgiLight's market analysis. OTC Financial Network, a division of National Financial Communications Corp., is a financial communications and investor relations firm specializing in the representation of micro-cap companies. Forward-looking statements in this release are made pursuant to the ``safe harbor'' provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. OTC Financial Network, a division of National Financial Communications Corporation, serves as a special advisor to the featured Company and has received fees for services. This is not an offer to buy or sell securities. Information or opinions in this report are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Contact: SurgiLight Inc. OTC Financial Network J.T. Lin Geoffrey Eiten 407-482-4555 781-444-6100 x.13 Surgilight@aol.com geiten@otcfn.com surgilight.com

To: jjs64 who wrote (344)	5/3/2002 4:56:13 PM
From: StockDung	Respond to of 428

Surgilight turns out to be massive fraud Securities and Exchange Commission Washington, D.C. Litigation Release No. 17469 / April 11, 2002 Securities and Exchange Commission v. Surgilight, Inc., Jui-Teng Lin, Yuchin Lin and Aaron Tsai, Civil Action No. 6:02-CV-431-0RL-18KRS (G. Kendall Sharp, J.; Karla R. Spaulding, M.J.) (M.D. Fla. filed April 11, 2002) SEC Sues Laser Eye Surgery Company, Two Securities Law Recidivists and Others In Multi-Million Dollar Stock Manipulation The Securities and Exchange Commission ("Commission") today filed a civil action against a laser eye surgery company, two securities law recidivists, and a shell company broker in a multi-million dollar stock manipulation involving Surgilight, Inc., a publicly traded company headquartered in Orlando, Florida. One defendant, Dr. Jui-Teng Lin, was also indicted today by the United States Attorney's Office for the Eastern District of New York on related criminal charges. The Commission's complaint, filed in the United States District Court for the Middle District of Florida, alleges that Dr. Lin and his wife, Yuchin Lin, reaped over $1,700,000 in ill-gotten gains from manipulating the common stock of Surgilight. According to the complaint, the Lins artificially inflated the market price of Surgilight stock tenfold (from approximately $2.50 to over $25 per share) through a series of false and misleading press releases issued by Surgilight. The press releases detailed the company's purported ability to cure age-induced vision deterioration known as "Presbyopia." The Lins simultaneously dumped a substantial amount of Surgilight stock on an unsuspecting public through two nominee accounts and moved the proceeds through a series of offshore accounts to a domestic bank account held in Surgilight's name that they controlled. The Lins settled a prior civil action brought by the Commission involving another laser eye surgery company in September 1998 [see SEC v. Jui-Teng Lin and Yuchin Lin, Litigation Release No. 15870 (Sept. 3, 1998)]. The Commission further alleges that the Lins were assisted by Aaron Tsai of Henderson, Kentucky. According to the complaint, Tsai sold the Lins the publicly traded shell that became Surgilight, supplied the stock that was dumped out of the nominee accounts and, after Surgilight became a publicly-held entity, remained with the company as a consultant. At the height of the manipulation, Tsai sold over $1,000,000 worth of Surgilight stock for his own account. The Commission charges Dr. Lin with violations of Sections 5(a), 5(c), and 17(a) of the Securities Act of 1933 ("Securities Act") and Sections 10(b), 13(d), and 16(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rules 10b-5, 13d-1, 13d-2, 16a-2, and 16a-3 thereunder. Ms. Lin and Surgilight are charged with violations of Sections 5(a), 5(c), and 17(a) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder. Tsai is charged with violations of Sections 5(a) and 5(c) of the Securities Act and aiding and abetting Dr. Lin and Ms. Lin's violations of Section 10(b) of the Exchange Act and Rules 10b-5 thereunder. The Commission seeks permanent injunctions, disgorgement of ill-gotten gains with prejudgment interest, and civil penalties from all defendants and an officer and director bar against Dr. Lin. The Commission acknowledges assistance provided by NASD Regulation Inc. and the United States Attorney's Office for the Eastern District of New York in this matter. For tips on how to avoid Internet "pump-and-dump" stock manipulation schemes, visit sec.gov. For more information about Internet fraud, visit sec.gov. To report suspicious activity involving possible Internet fraud, visit sec.gov. SEC Complaint in this matter.

To: jjs64 who wrote (344)	5/3/2002 4:57:09 PM
From: StockDung	Read Replies (1) \| Respond to of 428

Surgilight's ex-chief executive indicted A federal grand jury indicted the former chief executive of Orlando-based Surgilight Inc. Thursday on securities fraud and money-laundering charges stemming from an alleged pump-and-dump stock scheme that cost investors millions. The indictment in New York accuses Jui-Teng Lin, 54, of issuing false and misleading news releases in 1999 and early 2000 to promote a new optical laser system that promised to reverse the effects of presbyopia, a vision problem that affects nearly everyone older than 45. The condition is typically treated with reading glasses. The allegedly false releases contained claims that the company had developed infrared lasers capable of correcting presbyopia, and that the equipment was being tested at major medical centers around the world. According to the indictment, Surgilight's stock price soared tenfold -- from $2.50 a share to about $25 -- between December 1999 and January 2000. When the stock was fully inflated, the indictment alleges, Lin dumped a large amount of stock through two brokerage accounts he maintained in Flushing, N.Y., and transferred $1.7 million in proceeds from the stock sales to Taiwan. If convicted, Lin faces a maximum of 10 years on the securities fraud charge and 20 years on each of two money-laundering charges. The U.S. Attorney for the Eastern District of New York and the U.S. Postal Inspection Service jointly announced the charges. The U.S. Securities and Exchange Commission, in a separate civil action Thursday, charged Lin; his wife, Yuchin Lin, 50; and Aaron Tsai, 33; with five securities violations related to the same alleged scheme. Those charges claim that the Lins and Tsai, a financial adviser, had roles in a ploy that yielded $3 million in gains from stock sales. The SEC suit details the alleged pump and dump operation. In addition, it accuses Tsai of arranging a reverse stock merger in March 1999 that allowed Lin to take his private company public using a shell company. According to the SEC suit, Surgilight's stock price collapsed after the company failed to deliver on its promises, costing investors millions. The suit asks that the three forfeit gains from the stock sales, pay fines and be enjoined from future securities violations. Lin, who founded Surgilight in 1998, resigned as chairman and CEO last summer. Surgilight stock lost 2 cents a share Thursday to close at 28 cents.

To: jjs64 who wrote (344)	10/2/2002 1:24:36 PM
From: StockDung	Respond to of 428

IS 13 CENTS A LUCKY NUMBER? CNLG - CONOLOG CORP Last Price: 0.13 at 13:07 EDT Change: Down 0.09 (-40.91%) High: 0.22 at 9:31 EDT Low: 0.13 at 13:06 EDT Open: 0.22 Previous Close: 0.22 on 9/30 Volume: 95,775 30-Day Avg. Volume: 21,000 Shares Outstanding: 4,382,000 Market Cap.: 569,660 52-Week High: 1.69 52-Week Low: 0.13 Beta: 0.50 Yield: Nil P/E Ratio: Not Material EPS: -2.14 Currency Units: US Dollar Exchange/Delay: Nasdaq: 15 minutes Confirm all data with your broker or financial advisor before trading. Data by: S&P ComStock